Sumatriptan Spray
Product Images NDC 69097-644

11 FDA label images from Cipla Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 69097-644). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (03eac73c 4dcc 4cc5 B0b1 28820f24f390 01)

Image (03eac73c 4dcc 4cc5 B0b1 28820f24f390 01)
Chemical structure of sumatriptan showing its molecular framework with substituent groups including a sulfonamide and dimethylaminoethyl side chain.*
FDA Label Image

Image (03eac73c 4dcc 4cc5 B0b1 28820f24f390 02)

Image (03eac73c 4dcc 4cc5 B0b1 28820f24f390 02)
A line graph depicting the estimated probability of response over time in minutes from the initial dose for Sumatriptan at doses of 5 mg, 10 mg, and 20 mg compared to placebo. The graph shows increased probabilities for higher doses within 120 minutes.*
FDA Label Image

Image (03eac73c 4dcc 4cc5 B0b1 28820f24f390 03)

Image (03eac73c 4dcc 4cc5 B0b1 28820f24f390 03)
A line graph depicting the estimated probability of remediation or rescue over time in hours from the initial dose. Four curves represent placebo, 5 mg, 10 mg, and 20 mg dosages, with probabilities increasing over time and leveling off between 60% and 80% by 24 hours.*
FDA Label Image

1 (03eac73c 4dcc 4cc5 B0b1 28820f24f390 04)

1 (03eac73c 4dcc 4cc5 B0b1 28820f24f390 04)
Illustration showing hands peeling back the protective foil of a Sumatriptan nasal spray single-dose blister pack. The packaging displays the Cipla USA Inc. label and product details on a card inside the blister.*
FDA Label Image

2 (03eac73c 4dcc 4cc5 B0b1 28820f24f390 05)

2 (03eac73c 4dcc 4cc5 B0b1 28820f24f390 05)
An instructional illustration showing a woman holding a tissue to her nose, demonstrating nasal area coverage, likely related to the use of a nasal spray. The image depicts proper handling or application technique for a nasal spray product.*
FDA Label Image

3 (03eac73c 4dcc 4cc5 B0b1 28820f24f390 06)

3 (03eac73c 4dcc 4cc5 B0b1 28820f24f390 06)
An instructional illustration showing a woman demonstrating the use of a nasal spray. She is holding her finger below her nostril, indicating the proper positioning of the spray in the nasal passage, likely related to the administration of Sumatriptan nasal spray.*
FDA Label Image

4 (03eac73c 4dcc 4cc5 B0b1 28820f24f390 07)

4 (03eac73c 4dcc 4cc5 B0b1 28820f24f390 07)
An instructional illustration showing a hand holding a Sumatriptan nasal spray device labeled 20 mg. The image highlights and labels two specific parts of the spray device: the nozzle and the plunger, demonstrating the correct grip for use.*
FDA Label Image

5 (03eac73c 4dcc 4cc5 B0b1 28820f24f390 08)

5 (03eac73c 4dcc 4cc5 B0b1 28820f24f390 08)
An instructional illustration showing a woman using a sumatriptan nasal spray. She is holding the device close to her nostril with her finger positioned to activate the spray, demonstrating proper administration technique for nasal delivery.*
FDA Label Image

6 (03eac73c 4dcc 4cc5 B0b1 28820f24f390 09)

6 (03eac73c 4dcc 4cc5 B0b1 28820f24f390 09)
Illustration showing a woman demonstrating the use of a nasal spray device, holding it near her nostrils to indicate how to administer the spray. No text or branding is visible on the device.*
FDA Label Image

Image (03eac73c 4dcc 4cc5 B0b1 28820f24f390 10)

Image (03eac73c 4dcc 4cc5 B0b1 28820f24f390 10)
Label for Sumatriptan Nasal Spray, USP 20 mg, manufactured by Cipla USA Inc. This nasal spray label indicates each dose contains 20 mg of sumatriptan for intranasal use only. Storage instructions specify keeping between 36°F and 86°F (2°C and 30°C) and protecting from light. The label includes the Cipla logo, NDC 69097-644-48, and spaces for lot number and expiration date.*
FDA Label Image

2 (03eac73c 4dcc 4cc5 B0b1 28820f24f390 11)

2 (03eac73c 4dcc 4cc5 B0b1 28820f24f390 11)
Packaging label for Sumatriptan Nasal Spray, USP 20 mg by Cipla USA Inc. The label indicates 0.1 mL per unit with 6 nasal spray units in the package. The NDC is 69097-644-48 and the product is marked Rx Only. The label includes storage instructions and manufacturer information for Cipla Ltd. India and Cipla USA Inc. The design features a white background with blue accents and includes a barcode and spaces for pharmacy label and batch overprinting.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.